Rankings
▼
Calendar
SRPT FY 2022 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$933M
+32.9% YoY
Gross Profit
$793M
85.0% margin
Operating Income
-$536M
-57.5% margin
Net Income
-$703M
-75.4% margin
EPS (Diluted)
$-8.03
Cash Flow
Operating Cash Flow
-$325M
Free Cash Flow
-$358M
Stock-Based Comp.
$233M
Balance Sheet
Total Assets
$3.1B
Total Liabilities
$2.7B
Stockholders' Equity
$385M
Cash & Equivalents
$967M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$933M
$702M
+32.9%
Gross Profit
$793M
$605M
+31.1%
Operating Income
-$536M
-$460M
-16.6%
Net Income
-$703M
-$419M
-68.0%
← Q4 2021
All Quarters
Q1 2022 →